AcquisitionOther
Vivos Therapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Vivos Therapeutics, Inc. -> target · $10 Million
"We expect this transaction to add more than $10 million to our stockholders' equity, and we now own half of a test designed to identify patients whose sleep apnea may be contributing to chronic disease.
Open source record (SEC) ↗